SECURITY AGREEMENTSecurity Agreement • July 13th, 2018 • Medite Cancer Diagnostics, Inc. • Surgical & medical instruments & apparatus • New York
THIS SECURITY AGREEMENT (as amended, restated, supplemented or otherwise modified from time to time, this “Agreement”) dated as of June ____, 2018, by and among MEDITE Cancer Diagnostics, Inc., a Delaware corporation (the “Company”, and together with each of the undersigned direct and indirect Subsidiaries from time to time and any other Person who becomes a party to this Agreement by execution of a joinder in the form of Exhibit A attached hereto being hereinafter sometimes referred to individually as a “Debtor” and, collectively, as the “Debtors”), and GPB Debt Holdings II, LLC, a Delaware limited liability company, in its capacity as Collateral Agent (the “Collateral Agent”), for the Purchasers (collectively with their successors and permitted assigns, the “Secured Party”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 13th, 2018 • Medite Cancer Diagnostics, Inc. • Surgical & medical instruments & apparatus • New York
This Securities Purchase Agreement (as amended, restated, supplemented or otherwise modified from time to time, this “Agreement”) is dated as of June ____, 2018, between MEDITE Cancer Diagnostics, Inc., a Delaware corporation (the “Company”), and the purchasers identified on the signature pages hereto (including its successors and permitted assigns, the “Purchasers”).
12% SECURED CONVERTIBLE NOTEConvertible Security Agreement • July 13th, 2018 • Medite Cancer Diagnostics, Inc. • Surgical & medical instruments & apparatus • New York
THIS 12% SECURED CONVERTIBLE NOTE is issued by MEDITE CANCER DIAGNOSTICS, INC., a Delaware corporation (the “Company”) (this note, the “Note”).
FIRST AMENDMENT TO FORBEARANCE AGREEMENTForbearance Agreement • July 13th, 2018 • Medite Cancer Diagnostics, Inc. • Surgical & medical instruments & apparatus
This FIRST AMENDMENT TO FORBEARANCE AGREEMENT (this “Amendment”) is entered into as of June 29, 2018, by and among MEDITE Cancer Diagnostics, Inc., a Delaware corporation (“Borrower”), and GPB Debt Holdings II LLC, a Delaware limited liability company (“Lender”). Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Transaction Documents (as hereinafter defined).
